Corrado Barbui

Corrado Barbui's AcademicInfluence.com Rankings

Corrado Barbui

Philosophy

#5361

World Rank

#8132

Historical Rank

Logic

#2649

World Rank

#3667

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Corrado Barbui's Degrees

PhD Medicine University of Milan
Doctorate Medicine University of Milan

Why Is Corrado Barbui Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Corrado Barbui's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis (2013) (1929)
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis (2009) (1479)
Imputing missing standard deviations in meta-analyses can provide accurate results. (2006) (1083)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. (2016) (798)
What is the European Medicines Agency? (2012) (569)
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis (2018) (498)
Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis (2011) (489)
Mental health and psychosocial support in humanitarian settings: linking practice and research (2011) (475)
Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis (2017) (451)
How often do patients with psychosis fail to adhere to treatment programmes? A systematic review (2003) (347)
Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations (2011) (332)
What is an individual patient data meta-analysis? (2007) (293)
Antidepressants and the risk of suicidal behaviors. (2004) (255)
Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies (2009) (243)
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. (2015) (233)
Imputing response rates from means and standard deviations in meta-analyses (2005) (228)
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies (2017) (222)
Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. (2015) (219)
Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis (2011) (193)
Clinical interventions for treatment non-adherence in psychosis: Meta-analysis (2003) (192)
WHO Mental Health Gap Action Programme (mhGAP) Intervention Guide: a systematic review of evidence from low and middle-income countries (2017) (187)
Escitalopram versus other antidepressive agents for depression. (2009) (184)
Long-Term Medical Conditions and Major Depression: Strength of Association for Specific Conditions in the General Population (2005) (184)
Mirtazapine versus other antidepressive agents for depression. (2010) (179)
Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials (2001) (171)
Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. (2005) (170)
Fluoxetine versus other types of pharmacotherapy for depression. (2013) (166)
Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis (2017) (157)
Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review (2002) (157)
Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises. (2015) (154)
Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD). (2007) (149)
Poverty and Mental Illness (1997) (143)
Does the addition of a second antipsychotic drug improve clozapine treatment? (2009) (142)
What is an intention to treat analysis? (2008) (142)
Citalopram versus other anti-depressive agents for depression. (2012) (137)
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future (2020) (129)
Sertraline versus other antidepressive agents for depression. (2009) (126)
Non-Specialist Psychosocial Interventions for Children and Adolescents with Intellectual Disability or Lower-Functioning Autism Spectrum Disorders: A Systematic Review (2013) (124)
Drug-Induced Depression: A Systematic Review to Inform Clinical Practice (2004) (119)
Antidepressants for the treatment of depression in people with cancer. (2023) (119)
Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates (1999) (118)
Determinants of subjective quality of life in patients attending community‐based mental health services. The South‐Verona Outcome Project 5 (2002) (118)
Challenges in Developing Evidence-Based Recommendations Using the GRADE Approach: The Case of Mental, Neurological, and Substance Use Disorders (2010) (116)
Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials (2007) (115)
Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis. (2015) (108)
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. (2009) (105)
Fluvoxamine versus other anti-depressive agents for depression. (2010) (102)
What is a multiple treatments meta-analysis? (2012) (100)
Management of acute stress, PTSD, and bereavement: WHO recommendations. (2013) (99)
Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review. (2020) (97)
Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries (2006) (97)
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis (2019) (97)
Focused psychosocial interventions for children in low-resource humanitarian settings: a systematic review and individual participant data meta-analysis. (2018) (90)
Suicide, depression, and antidepressants (2005) (90)
Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants (2010) (88)
Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta‐analysis (2018) (87)
Amitriptyline for depression. (2007) (86)
Hydroxyzine for generalised anxiety disorder. (2010) (86)
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials. (2013) (86)
Psychotherapies for depression in low‐ and middle‐income countries: a meta‐analysis (2018) (85)
Investigation of corpus callosum in schizophrenia with diffusion imaging (2005) (85)
Monitoring community psychiatric services in Italy: differences between patients who leave care and those who stay in treatment. (2002) (84)
Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages? (2008) (83)
Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. (2000) (82)
Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression (2010) (81)
Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. (2005) (81)
Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials (2006) (78)
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003–2004 (2007) (77)
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. (2008) (76)
Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study (2005) (76)
Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis (2020) (74)
Are we going to increase the use of antidepressants up to that of benzodiazepines? (2004) (74)
Duloxetine versus other anti-depressive agents for depression. (2012) (72)
Mortality and cause of death among psychiatric patients: a 20-year case-register study in an area with a community-based system of care (2009) (72)
Implementation of treatment guidelines for specialist mental health care. (2012) (71)
Efficacy of interventions to reduce coercive treatment in mental health services: umbrella review of randomised evidence (2020) (69)
Are all antidepressants really the same? The case of fluoxetine: a systematic review. (2006) (68)
Metareview on Short-Term Effectiveness and Safety of Antidepressants for Depression: An Evidence-Based Approach to Inform Clinical Practice (2007) (67)
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies (2017) (66)
Sex Differences in the Subjective Tolerability of Antipsychotic Drugs (2005) (65)
World Health Organization Guidelines for Management of Acute Stress, PTSD, and Bereavement: Key Challenges on the Road Ahead (2014) (65)
Choice of data extraction tools for systematic reviews depends on resources and review complexity. (2009) (64)
Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies (2014) (62)
Low dosage tricyclic antidepressants for depression. (2003) (61)
Second-Generation Antipsychotics and Risk of Cerebrovascular Accidents in the Elderly (2005) (59)
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations (2020) (59)
The evidence–practice gap in specialist mental healthcare: Systematic review and meta-analysis of guideline implementation studies (2017) (58)
Fluoxetine versus other types of pharmacotherapy for depression. (2005) (56)
Assessment of Medication Adherence in Patients With Schizophrenia: The Achilles Heel of Adherence Research (2008) (55)
Pharmacological treatment of mental disorders in primary health care (2009) (54)
Depression in adults: drug and physical treatments. (2011) (54)
A systematic review of cognitive effects of exercise in depression (2017) (54)
Antidepressant drug prescribing among elderly subjects: a population‐based study (2005) (53)
Antidepressant drug use in Lombardy, Italy: a population-based study. (2004) (51)
Psychological and Psychosomatic Symptoms of Second Victims of Adverse Events: a Systematic Review and Meta-Analysis (2019) (51)
Milnacipran versus other antidepressive agents for depression. (2009) (51)
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation (2007) (50)
Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis. (2021) (50)
Amitriptyline versus other types of pharmacotherapy for depression. (2003) (49)
Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta‐analysis of observational studies (2015) (49)
Antipsychotic use and risk of life‐threatening medical events: umbrella review of observational studies (2019) (48)
Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe (2013) (48)
"Wish Bias" in Antidepressant Drug Trials? (2004) (48)
Paroxetine versus other anti-depressive agents for depression. (2007) (47)
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy (2018) (47)
Seven criteria for improving effectiveness trials in psychiatry (2006) (47)
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval (2016) (46)
Off‐label and non‐classical prescriptions of antipsychotic agents in ordinary in‐patient practice (2004) (46)
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System (2020) (46)
Cortical white-matter microstructure in schizophrenia. Diffusion imaging study. (2007) (45)
Antidepressants for the treatment of depression in people with cancer. (2015) (44)
Antidepressants versus placebo for panic disorder in adults. (2013) (44)
Violence in psychiatric units: a 7-year Italian study of persistently assaultive patients. (2006) (43)
Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study (2007) (42)
Sertraline versus other antidepressive agents for depression. (2010) (41)
Aripiprazole Versus Haloperidol in Combination With Clozapine for Treatment-Resistant Schizophrenia in Routine Clinical Care: A Randomized, Controlled Trial (2011) (41)
Avoidable mortality of psychiatric patients in an area with a community‐based system of mental health care (2007) (41)
Validity of the impact factor of journals as a measure of randomized controlled trial quality. (2006) (41)
An overview of systematic reviews on mental health promotion, prevention, and treatment of common mental disorders for refugees, asylum seekers, and internally displaced persons (2019) (40)
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study (2014) (40)
Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999–2002 (2006) (40)
Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study (2015) (40)
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature (2017) (39)
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs) (Withdrawn Paper. 2006, art no. CD002791) (2006) (39)
Sertraline versus other antidepressive agents for depression. (2010) (39)
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials. (2016) (39)
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis. (2021) (39)
Amitriptyline for inpatients and SSRIs for outpatients with depression? Systematic review and meta-regression analysis. (2004) (38)
Closing forensic psychiatric hospitals in Italy: a new revolution begins? (2015) (37)
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications (2014) (37)
Mental health services for infectious disease outbreaks including COVID-19: a rapid systematic review (2020) (36)
Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises (2016) (36)
Benzodiazepines versus placebo for panic disorder in adults. (2013) (35)
Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis. (2008) (35)
Generic olanzapine: health authority opportunity or nightmare? (2008) (35)
Prescribing second-generation antipsychotics and the evolving standard of care in Italy. (2002) (35)
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis (2017) (35)
Long-Term Treatment of Depression with Antidepressants: A Systematic Narrative Review (2007) (35)
Effectiveness of Self-Help Plus in Preventing Mental Disorders in Refugees and Asylum Seekers in Western Europe: A Multinational Randomized Controlled Trial (2021) (34)
Comparison of Patient and Clinician Perspectives in the Assessment of Antipsychotic Medication Adherence (2009) (33)
Cerebral atrophy and white matter disruption in chronic schizophrenia (2007) (33)
Antidepressants and benzodiazepines for panic disorder in adults. (2016) (33)
Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis (2022) (33)
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism (2012) (32)
State of psychiatry in Italy 35 years after psychiatric reform. A critical appraisal of national and local data (2012) (32)
What are evidence-based treatment recommendations? (2011) (31)
WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). (2006) (30)
Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden (2013) (30)
Effectiveness of a WHO self‐help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial (2022) (30)
Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries (2019) (30)
Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database (2001) (30)
Identification and management of depression in primary care settings. A meta-review of evidence (2006) (29)
Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis. (2015) (29)
What is a clinical trial protocol? (2010) (29)
Frequency and Adequacy of Depression Treatment in a Canadian Population Sample (2007) (29)
Antidepressant Drug Prescription and Risk of Abnormal Bleeding: A Case-Control Study (2009) (29)
Validity of indirect comparisons in meta-analysis (2007) (29)
Violence in psychiatric units (2006) (29)
Predicting costs of mental health care: a critical literature review (2007) (28)
EMA must improve the quality of its clinical trial reports (2011) (28)
Forty years without mental hospitals in Italy (2018) (28)
Implementation of treatment guidelines for specialist mental health care. (2016) (28)
Cross-sectional Database Analysis of Antidepressant Prescribing in Italy (2003) (27)
A cross‐sectional audit of benzodiazepine use among general practice patients (1998) (27)
Reducing stigma and discrimination associated with COVID-19: early stage pandemic rapid review and practical recommendations (2021) (27)
Forty years of antidepressant drug trials (2001) (27)
Esketamine for treatment resistant depression: a trick of smoke and mirrors? (2019) (27)
Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status (2001) (26)
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy (2005) (26)
Assessment of cerebral blood volume in schizophrenia: A magnetic resonance imaging study. (2007) (26)
Decisions on WHO’s essential medicines need more scrutiny (2014) (26)
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial (2014) (25)
Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case–control study (2015) (25)
Guideline implementation strategies for specialist mental healthcare (2013) (25)
Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis (2009) (25)
Aripiprazole Versus Haloperidol in Combination With Clozapine for Treatment-Resistant Schizophrenia: A 12-Month, Randomized, Naturalistic Trial (2013) (25)
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review. (2008) (24)
Fluoxetine dose and outcome in antidepressant drug trials (2002) (24)
Global mental health: how are we doing? (2018) (24)
Direct costs of schizophrenia and related disorders in Italian community mental health services: a multicenter, prospective 1-year followup study. (2004) (24)
Does placebo help establish equivalence in trials of new antidepressants? (2000) (24)
A simple approach to manage dosages in drug-epidemiology research (2008) (24)
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders (2012) (24)
Trends in the use of the Italian Mental Health Act, 1979–1997 (2004) (23)
Antidepressant agents: from tricyclics to serotonin uptake inhibitors (1998) (23)
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches (2020) (23)
Sharing all types of clinical data and harmonizing journal standards (2016) (23)
Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil (2018) (23)
Effect of medication-related factors on adherence in people with schizophrenia: A European multi-centre study (2010) (23)
Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials (2019) (23)
Influence of patient co-payments on atypical antipsychotic choice in Poland (2011) (23)
Azapirones versus placebo for panic disorder in adults. (2014) (22)
Cost and outcome implications of using typical and atypical antipsychotics in ordinary practice in Italy. (2003) (22)
Adherence to generic v. brand antidepressant treatment and the key role of health system factors (2014) (22)
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia (2009) (22)
First‐generation antipsychotics and QTc: any role for mediating variables? (2016) (21)
Low-dose neuroleptic therapy and relapse in schizophrenia: meta-analysis of randomized controlled trials (1996) (21)
Efficacy and safety of anti-epileptic drugs in patients with active convulsive seizures when no IV access is available: Systematic review and meta-analysis (2016) (21)
Patterns of benzodiazepine use in a Canadian population sample (2009) (21)
A Systematic Review of the Use of Telepsychiatry in Depression (2020) (21)
Benzodiazepines and risk of dementia: true association or reverse causation? (2013) (20)
Prevalence and Correlates of Psychological Distress and Psychiatric Disorders in Asylum Seekers and Refugees Resettled in an Italian Catchment Area (2018) (20)
Venlafaxine for major depression (2007) (20)
Clinical and regulatory implications of active run‐in phases in long‐term studies for bipolar disorder (2014) (20)
Discharges of Patients from Public Psychiatric Hospitals in Italy between 1994 and 2000 (2003) (19)
Relationship Between Quality of Reports of Antidepressant Randomized Controlled Trials and Treatment Estimates: Systematic Review, Meta-Analysis, and Meta-Regression Analysis (2007) (19)
Clozapine-treated subjects with treatment-resistant schizophrenia: a systematic review of experimental and observational studies (2002) (19)
Why it is important to include unpublished data in systematic reviews (2011) (19)
Development and implementation of guidelines for the management of depression: a systematic review (2020) (19)
Past use of selective serotonin reuptake inhibitors and the risk of cerebrovascular events in the elderly (2005) (18)
Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis (2018) (18)
Paroxetine versus other anti-depressive agents for depression. (2014) (18)
Efficacy and Tolerability of Milnacipran in the Treatment of Major Depression in Comparison with Other Antidepressants (2008) (18)
Potential to Enhance the Prescribing of Generic Drugs in Patients with Mental Health Problems in Austria; Implications for the Future (2013) (17)
If You Could Only Choose Five Psychotropic Medicines: Updating the Interagency Emergency Health Kit (2011) (17)
Prevention and management of physical health conditions in adults with severe mental disorders: WHO recommendations (2021) (17)
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial (2013) (17)
Rigour of development of clinical practice guidelines for the pharmacological treatment of bipolar disorder: systematic review. (2015) (17)
Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants (2022) (17)
Epidemiology of first- and second-generation antipsychotic agents in Lombardy, Italy. (2005) (16)
Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies (2018) (16)
Adverse effects of antipsychotic drugs: survey of doctors’ versus patients’ perspective (2010) (16)
Antipsychotic drug prescribing in the elderly is cause for concern (2004) (16)
Dealing With Adverse Events: A Meta-analysis on Second Victims’ Coping Strategies (2020) (16)
Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications (2013) (16)
Parent skills training for parents of children or adults with developmental disorders: systematic review and meta-analysis protocol (2014) (16)
Health status, resource consumption, and costs of dysthymia. A multi-center two-year longitudinal study. (2006) (16)
Pragmatic design in randomized controlled trials (2014) (15)
Discussion of the updated WHO recommendations for mental, neurological, and substance use disorders. (2016) (15)
Relationship between Self-Reported and Observer-Reported Ratings for Psychopathology in Psychiatric Inpatients (2007) (15)
Effect of Second-Generation Antipsychotics on Employment and Productivity in Individuals with Schizophrenia (2012) (15)
A New Approach to Psychiatric Drug Approval in Europe (2013) (15)
Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence. (2019) (15)
The Qualyop Project 1: Monitoring the Dismantlement of Italian Public Psychiatric Hospitals Characteristics of Patients Scheduled for Discharge (1999) (14)
The Italian mental health-care reform: public health lessons (2018) (14)
Update of suicide trends in Italy from 1986 to 1996 (2002) (14)
Superiority, equivalence or non-inferiority? (2009) (14)
Head-To-Head Comparison of the Costs of Atypical Antipsychotics (2005) (14)
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study (2020) (14)
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey (2013) (14)
Vortioxetine for depression in adults (2017) (14)
Cochrane for global mental health. (2017) (14)
Cluster randomised trials (2011) (14)
Generic atypical antipsychotic drugs in Belgium: their influence and implications. (2013) (14)
Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries (2006) (14)
Assessing risk of bias in randomized controlled trials (2010) (14)
Epidemiological impact of antidepressant and antipsychotic drugs on the general population (2006) (14)
Recent approaches to provision of mental healthcare in refugee populations (2018) (13)
Antidepressant pharmacoepidemiology in a general population sample. (2005) (13)
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base (2016) (13)
What is a Cochrane review? (2011) (13)
Direct Costs of Schizophrenia in Italian Community Psychiatric Services (2012) (13)
What is the WHO essential medicines list? (2012) (13)
Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials (2018) (13)
Thirtieth birthday of the Italian psychiatric reform: research for identifying its active ingredients is urgently needed (2008) (13)
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis. (2019) (13)
Worrying Patterns of Out-Patient Psychotropic Drug Prescribing in Children and Adolescents (2005) (13)
What is a risk ratio? (2007) (13)
Improving access to medicines for mental disorders in low-resource settings: some achievements but still a long road ahead (2015) (13)
Reducing the Risk of Cognitive Decline and Dementia: WHO Recommendations (2022) (12)
Bias in the evaluation of antidepressants (2005) (12)
Schizophrenia trials conducted in African countries: a drop of evidence in the ocean of morbidity? (2012) (12)
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare (2013) (12)
A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD (2021) (11)
Ranking antidepressants – Authors' reply (2009) (11)
Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study (2021) (11)
Behavioural activation therapy for depression in adults with non-communicable diseases. (2019) (11)
Risk of suicidal behaviour in adults taking antidepressants (2009) (11)
Patient co-payments do influence atypical antipsychotic choice in Poland; implications once generic atypical are available. (2011) (11)
Why internal and external validity of experimental studies are relevant for clinical practice? (2009) (11)
Psychosocial interventions for children exposed to traumatic events in low- and middle-income countries: study protocol of an individual patient data meta-analysis (2014) (11)
Clinical databases of patients receiving antidepressants. The missing link between research and practice? (2002) (11)
Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review (2019) (11)
Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review. (2020) (11)
Implementation of treatment guidelines for specialist mental health care. (2014) (10)
Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders: findings from the STAR Network Depot Study (2020) (10)
Tryptophan and depression (1997) (10)
QUALYOP Project 2: monitoring the dismantling of Italian psychiatric hospitals. Psychotropic drug use in 1072 inpatients (1999) (10)
Antidepressants and suicide symptoms: compelling new insights from the FDA’s analysis of individual patient level data (2008) (10)
Regulatory issues in Europe. (2001) (10)
Access to and Use of Psychiatric Services by Migrants Resettled in Northern Italy (2018) (10)
Regulatory policies on medicines for psychiatric disorders: is Europe on target? (2007) (10)
Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications (2013) (10)
Stressful life events and social health factors in women using anxiolytics and antidepressants: an Italian observational study in community pharmacies. (2011) (10)
The prevalence of antidepressant and antipsychotic drug prescribing in Lombardy, Italy. (2005) (10)
Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies (2022) (10)
Impact of maternal mental health interventions on child-related outcomes in low- and middle-income countries: a systematic review and meta-analysis (2020) (10)
Using GRADE to update WHO recommendations for MNS. (2015) (10)
Mediators of focused psychosocial support interventions for children in low-resource humanitarian settings: analysis from an Individual Participant Dataset with 3,143 participants. (2019) (10)
Randomized Trials Published in Chinese or Western Journals: Comparative Empirical Analysis (2012) (10)
Dichotomizing rating scale scores in psychiatry: a bad idea? (2012) (9)
CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation? (2006) (9)
Effectiveness of self-help plus (SH+) in reducing anxiety and post-traumatic symptomatology among care home workers during the COVID-19 pandemic: a randomized controlled trial (2021) (9)
Explanatory and pragmatic trials (2007) (9)
Mapping actions to improve access to medicines for mental disorders in low and middle income countries (2017) (9)
Development of a registry for monitoring psychotropic drug prescriptions: aims, methods and implications for ordinary practice and research (2005) (9)
Meta-analysis of virtual reality exposure therapy for social anxiety disorder (2021) (9)
Can systematic reviews contribute to regulatory decisions? (2017) (9)
Economic Evaluation of Antidepressive Agents: A Systematic Critique of Experimental and Observational Studies (2003) (9)
Clinical trials of new antipsychotics: a critical appraisal. (1999) (9)
Trajectories of psychological symptoms and resilience in conflict-affected children in low- and middle-income countries. (2020) (9)
Mild depression in general practice: is the automatism of antidepressant prescribing an evidence‐based approach? (2006) (9)
Comparative efficacy and acceptability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis (2016) (9)
Suicide prevention strategies and mental disorders (2009) (9)
Patient Opinions on the Benefits of Treatment Programs in Residential Psychiatric Care (2004) (9)
Guideline implementation in mental health: Current status and future goals (2012) (9)
Regulatory science in Europe: the case of schizophrenia trials (2013) (9)
Antidepressant and antipsychotic drug prescribing in Lombardy (2006) (9)
Evidence-based interventions for global mental health: role and mission of a new Cochrane initiative. (2017) (9)
Addressing stress, depression, and anxiety in people exposed to traumatic events in humanitarian settings: A systematic review and meta-analysis of psychosocial interventions (2018) (8)
Safety of psychotropic medications in people with COVID-19 (2020) (8)
Mental disorders and conditions specifically related to stress (2013) (8)
Celebrating the 40th anniversary of the Italian Mental Health reform (2018) (8)
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis (2019) (8)
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study (2022) (8)
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis. (2022) (8)
International Dosage Differences in Fluoxetine Clinical Trials (2005) (7)
Psychotropic drug epidemiology: The road travelled, the road ahead (2005) (7)
Do antidepressants prolong the QT interval? (2013) (7)
Depression in adults (drug and other physical treatments) (2007) (7)
Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison. (2005) (7)
Agomelatine and the brave old world of narrative-based medicine (2012) (7)
Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health (2020) (7)
depression: systematic review and meta-analysis Efficacy of antidepressants and benzodiazepines in minor (2011) (7)
Publication bias in systematic reviews. (2007) (7)
Generating psychotropic drug exposure data from computer-based medical records (2006) (7)
Access to psychotropic medicines in low-resource settings. (2016) (7)
Drug epidemiology in Italy: methods and ethical issues. The example of psychiatry (2001) (6)
Evidence-based psychopharmacology: an agenda for the future (2007) (6)
Association of traumatic events with levels of psychological distress and depressive symptoms in male asylum seekers and refugees resettled in Italy (2020) (6)
Access and use of psychotropic medicines in low-resource settings (2015) (6)
Novel melatonin-based treatments for major depression (2012) (6)
Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study. (2022) (6)
The BPRS-E as predictor of length of stay in a residential facility. (2005) (6)
Antidepressant dose and the risk of deliberate self-harm (2014) (6)
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine (2015) (6)
Varying and "atypical" indications for atypical antipsychotics (2003) (6)
Global Mental Health 3 Mental health and psychosocial support in humanitarian settings: linking practice and research (2011) (6)
Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs (2011) (6)
Community-based interventions for improving mental health in refugee children and adolescents in high-income countries (2020) (6)
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial (2019) (6)
Intramuscular haloperidol plus promethazine is more effective and safer than haloperidol alone for rapid tranquillisation of agitated mentally ill patients (2008) (6)
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach (2008) (6)
Reviews and Meta-analyses of Psychotherapy Efficacy for Borderline Personality Disorder-Reply. (2017) (5)
Drug treatment modalities in psychiatric inpatient practice (2005) (5)
Primary-level and community worker interventions for the prevention of mental disorders and the promotion of well-being in low- and middle-income countries (2021) (5)
Systematic review of clinical interventions for reducing treatment non-adherence in psychosis (2003) (5)
Psychosocial interventions for Post-Traumatic Stress Disorder in refugees and asylum seekers (2017) (5)
What is a forest plot? (2006) (5)
Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study (2015) (5)
Allocation concealment and blinding in clinical trials (2008) (5)
Cochrane reviews impact on mental health policy and practice (2011) (5)
Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD). (2022) (5)
Real-world data on new users of atypical antipsychotics: characterisation, prescription patterns, healthcare costs and early cardio-metabolic occurrences from a large Italian database (2020) (5)
Prevalence and treatment of neurological and psychiatric disorders among tertiary hospitals in Pakistan; findings and implications (2020) (5)
Polycystic ovary syndrome and postpartum depression: a systematic review and meta-analysis of observational studies. (2021) (5)
Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness (2020) (5)
SSRI plus supportive care more effective than supportive care alone for mild to moderate depression (2009) (5)
Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future (2018) (5)
Antidepressants for the treatment of depression in patients with cancer (2014) (4)
Low-dose neuroleptic therapy and extrapyramidal side effects in schizophrenia: an effect size analysis (1996) (4)
Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance (2017) (4)
Outcome reporting bias in clinical trials (2009) (4)
New generation psychotropics and the automatism of prescribing (2005) (4)
Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study (2022) (4)
Attention-deficit/hyperactivity disorder (ADHD): from randomised controlled trials to evidence-based clinical services (2017) (4)
Does mental health staffing level affect antipsychotic prescribing? Analysis of Italian national statistics (2018) (4)
Global mental health: good news, bad news and responsibilities for the future (2019) (4)
Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study (2022) (4)
YRP.14 Service and non-service costs of psychiatric patients attending a community mental health centre in Italy (2002) (4)
Aripiprazole in Addition to Clozapine in Partially Responsive Patients with Schizophrenia: A Critical Review of Case Series (2008) (4)
Do Cochrane systematic reviews meet WHO needs? (2015) (4)
Geneva calling: WHO resolution on mental disorders (2012) (4)
Esketamine clinical trials: reply to Maju et al. (2020) (4)
Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis (2017) (4)
Parkinsonian axial signs in schizophrenia. (2017) (4)
Antidepressants for major depression disorder in older people: a network meta-analysis (2019) (4)
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review (2023) (4)
Conventional vs. atypical antipsychotic medications. (2006) (4)
Review: Atypical antipsychotics are effective adjuncts for treatment resistant depression but increase discontinuation due to adverse effects (2008) (3)
Public health psychopharmacology: a new research discipline comes of age? (2018) (3)
[Systematic review to evaluate the efficacy, acceptability and safety of second-generation antipsychotics for the treatment of unipolar and bipolar depression.] (2018) (3)
Scientists Against War: A Plea to World Leaders for Better Governance (2022) (3)
Depressive Disorder Needs an Evidence Base Commensurate with its Public Health Importance (2007) (3)
Evidence based psychopharmacology: a public health agenda for the future (2007) (3)
Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses (2020) (3)
Escitalopram versus other anti‐depressive agents for depression (2007) (3)
OLANZAPINE ON TRIAL. AUTHORS' REPLY (1998) (3)
Efficacy of physical activity interventions on psychological outcomes in refugee, asylum seeker and migrant populations: A systematic review and meta-analysis (2021) (3)
What is a factorial trial? (2013) (3)
Regulatory meta-analyses for the evaluation of psychotropic medicines. (2017) (3)
Ongoing initiatives within the Scottish National Health Service to affect the prescribing of SSRIs and their influence (2019) (3)
Preventing the mental health consequences of war in refugee populations (2022) (3)
Review: Antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania (2007) (3)
The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study (2021) (3)
The changing pattern of inpatient antipsychotic drug use in Italy. (2004) (3)
Global mental health: achievements, concerns and (unanswered) questions (2016) (3)
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT Turning clinical practice into research. An invitation to partecipate to the CHAT study (2006) (3)
Treatment Choices in Women with Bipolar Disorder Seeking Pregnancy: A Clinical Case Illustration (2013) (3)
Stopping antidepressants following depression (2016) (3)
What is a systematic review? (2006) (3)
Antipsychotic drug exposure and risk of myocardial infarction (2016) (3)
Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence (2020) (3)
Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy (2014) (3)
Regulatory requirements for psychological interventions. (2020) (3)
Venlafaxine versus other anti-depressive agents for depression. (2007) (3)
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database. (2022) (3)
Health status, resource consumption, and costs of dysthymic patients in Italian primary care (2004) (3)
Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials (2021) (3)
How does context influence the delivery of mental health interventions for asylum seekers and refugees in low- and middle-income countries? A qualitative systematic review (2021) (3)
Milnacipran versus other anti-depressive agents for depression (Protocol) (2007) (2)
Making the best use of available evidence: the case of new generation antidepressants (2009) (2)
Routine outcome monitoring in clinical practice: service and non-service costs of psychiatric patients attending a Community Mental Health Centre in Italy (2004) (2)
14:00 MULTIPLE-TREATMENTS META-ANALYSIS ON THE EFFICACY, ACCEPTABILITY AND TOLERABILITY OF 15 ANTIPSYCHOTICS DRUGS IN SCHIZOPHRENIA (2012) (2)
Review: maintenance antidepressants reduce risk of relapse but effect is not as great in recurrent depression (2009) (2)
Authors' reply (2015) (2)
Depression in adults: drug and physical treatments. (2011) (2)
Psychotropic drug use in an Italian psychiatric hospital: a two-year follow-up study (1999) (2)
Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure (2014) (2)
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level (2022) (2)
On the need for epidemiology in psychiatric sciences (2019) (2)
Comparative efficacy of anti-manic drugs in acute mania – Authors' reply (2012) (2)
Antidepressants versus placebo for generalised anxiety disorder (GAD) (2018) (2)
INterventions for Complex Traumatic Events (INCiTE): systematic review v1 (protocols.io.bdbni2me) (2019) (2)
Decision models in the evaluation of psychotropic drugs (2006) (2)
Conventional vs. atypical antipsychotic medications [Letter] (2006) (2)
Behavioural activation therapies for depression in adults with non-communicable diseases (2019) (2)
Cost-effectiveness of the Self-Help Plus Intervention for Adult Syrian Refugees Hosted in Turkey (2022) (2)
Systematic reviews and clinical decisions in psychiatry (2003) (2)
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database (2022) (2)
Venlafaxine for major depression More evidence that risks outweigh benefits for most patients (2007) (2)
Psychological and pharmacological interventions for PTSD and comorbid mental health problems following complex traumatic events: systematic review and component network meta-analysis (2020) (2)
Evidence-based medicine and routine clinical practice: the case of new antidepressant drugs (2002) (2)
Bupropion versus other antidepressive agents for depression (2014) (2)
Early pharmacological interventions for preventing post-traumatic stress disorder (PTSD): a network meta-analysis (2019) (1)
A systematic review of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the conduct of clinical trials in psychiatry (2002) (1)
Trajectories of psychosocial symptoms and wellbeing in asylum seekers and refugees exposed to traumatic events and resettled in Western Europe, Turkey, and Uganda (2022) (1)
Effect of Antipsychotic Drugs on Cerebrovascular Morbidity and Mortality: A Systematic Review (2006) (1)
Are second victims real victims? Evidence and reflections on the traumatic impact of adverse events in the medical setting (2020) (1)
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder (OCD) (2008) (1)
Forty-five years of schizophrenia trials in Italy: a survey (2012) (1)
Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study. (2022) (1)
Self-help plus for refugees and asylum seekers; study protocol for a series of individual participant data meta-analyses (2021) (1)
Adverse childhood experiences and global mental health: avenues to reduce the burden of child and adolescent mental disorders (2022) (1)
Symptoms of anxiety and depression during the COVID-19 pandemic in six European countries and Australia – Differences by prior mental disorders and migration status (2022) (1)
Review: Is aripiprazole as effective as risperidone in people with schizophrenia? (2010) (1)
Reply to the Comments by Doherty et al. (2020) (1)
Antipsychotics drug use in the elderly is cause for concern (2004) (1)
Clinical use of the diagnostic criteria for major depressive disorder (2015) (1)
Effectiveness of a stepped-care programme of internet-based psychological interventions for healthcare workers with psychological distress: Study protocol for the RESPOND healthcare workers randomised controlled trial (2022) (1)
From the 16th to the 21st Century: how we approach mental health problems and where do we go next? (2015) (1)
Correction to: Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness (2020) (1)
Expanding access to long-acting antipsychotics in low-income and middle-income countries. (2021) (1)
Review: antidepressant plus antipsychotic increases clinical response rates in psychotic depression (2007) (1)
Olanzapine on trial. (1998) (1)
Review: quetiapine leads to fewer withdrawals because of adverse effects in schizophrenia (1999) (1)
Revisioni sistematiche e decisioni cliniche in psichiatria (2003) (1)
Admissions for personality disorders in Italy from 1988 to 1998 (2006) (1)
Early pharmacological interventions for acute traumatic stress symptoms: a network meta-analysis (2020) (1)
CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials (2022) (1)
Alzheimer’s Association International Cohort Study of Chronic Neuropsychiatric Sequeale of SARS‐CoV‐2 (CNS‐SARS‐CoV‐2) (2020) (1)
Development of a core outcome set for multimorbidity trials in low/middle-income countries (COSMOS): study protocol (2021) (1)
Authors’ reply to Magrini and colleagues (2014) (1)
Antidepressants and the risk of suicidal behaviors. Authors' reply (2004) (1)
Medicine-based evidence: the case of antidepressants in patients with coronary artery disease (2018) (1)
Community-based interventions for improving mental health in refugee children and adolescents in high-income countries. (2022) (1)
Social and environmental adversities, neurobiological processes and mental disorders (2016) (1)
Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations (2020) (1)
Low dosage tricyclic antidepressants in depression. Authors' reply (2003) (1)
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries (2020) (1)
Preventing relapse in schizophrenia needs better evidence (2022) (1)
Safety of psychotropic medicines: looking beyond randomised evidence (2018) (1)
Pharmacological treatments in panic disorder in adults: a network meta-analysis (2020) (1)
Evaluation of dehospitalization policies of the former psychiatric hospitals of Regione Lombardia. QUALYOP study results. I: Structural resources, organizational procedures and activities (1996) (1)
Agomelatine versus placebo: a meta-analysis of published and unpublished trials (2012) (1)
Do selective serotonin reuptake inhibitors cause suicide?: Authors' reply to Raven (2005) (1)
PP262—Can authorities take full advantage of the availability of generic atypical antipsychotic drugs? implications for the future (2013) (1)
Do selective serotonin reuptake inhibitors cause suicide? Suicide rate of 15% in editorial is misleading - Reply (2005) (1)
Can authorities take full advantage of the availability of generic atypical antipsychotic drugs (2013) (1)
The Brief Psychiatric Rating Scale-Expanded Version as predictor of length of stay in a residential facility (2005) (1)
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. (2012) (1)
[The use of psychotropic drugs in an Italian psychiatric hospital: a two-year-long follow-up study]. (1999) (1)
Tridimensional reconstruction of cerebral volumetry in schizophrenia (2006) (1)
Reboxetine versus other antidepressive agents for depression (2018) (1)
COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence (2023) (1)
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression (2007) (1)
Getting Through the Quicksand of the Relationship between Drugs and Suicide (2011) (1)
Contents Vol. 74, 2005 (2005) (0)
PMH26 Real World Evidence Analysis of Atypical Antipsychotics, Cardio-Metabolic Profiles and Related Costs: DATA from the Italian Administrative Database of Fondazione Ricerca E Salute (RES) (2020) (0)
Re: Low dose tricyclics: making the best use of the available evidence (2017) (0)
Is the efficacy of selective serotonin reuptake inhibitors influenced by adverse events? Meta-regression and mediation analysis of placebo-controlled trials (2019) (0)
Amitriptyline versus other tricyclic drugs and selectivev serotonine reuptake inhibitors (SSRIs) for depression [Protocoll] (2000) (0)
Is the efficacy of antidepressants in panic disorder mediated by adverse events? A mediational analysis (2017) (0)
Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects (2007) (0)
Psychological and social interventions for the promotion of mental health in people living in low- and middle-income countries affected by humanitarian crises (2022) (0)
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial (2022) (0)
Review: multiple daily doses of antidepressants are not more effective than single daily doses (2002) (0)
[Everyday evidence and practice based medicine: an issue of antidepressants]. (2002) (0)
Continuing, Reducing, Switching or Stopping Antipsychotics in Clinically Stable Individuals with Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis (2022) (0)
Universal, selective and indicated interventions for supporting mental health at the workplace: an umbrella review of meta-analyses (2023) (0)
Title Dose equivalents of antidepressants : Evidence-based recommendations from randomized controlled trials (2018) (0)
Sharing (all) clinical data. (2016) (0)
Vortioxetine for depression in adults (Review) (2017) (0)
The WHO World Mental Health Report 2022: a new standard of care is emerging (2022) (0)
Which psychotherapy is effective in panic disorder? Findings and reflections from a systematic network meta-analysis (2021) (0)
Corrigendum to “[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism” [Schizophr. Res. 113 (2009) 41–48] (2012) (0)
Review: short-term benefit of escitalopram versus citalopram for depression uncertain, but big difference in French health insurance costs (2013) (0)
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations (2023) (0)
Patients’ opinions on the benefits of treatment programs in a residential facility (2004) (0)
Efficacy and tolerability of pharmacological treatments for personality disorders: A meta-analysis (2005) (0)
Hydroxyzine for generalised anxiety disorder (Protocol) (2007) (0)
The continuum of depressive experiences in cancer patients and the role of antidepressants. Results from a systematic review and meta-analysis (2018) (0)
Psychotropic drug epidemiology and systematic reviews of randomised clinical trials: The roads travelled, the roads ahead (2013) (0)
Bennie, M. and Bishop, I. and Godman, B. and Barbui, C. and Raschi, E. and Campbell, S. and Miranda, J. and Gustafsson, L.L. (2013) Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland? (2018) (0)
Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous interaction? (2007) (0)
Stressful life events and psychiatric drugs. An observational study conducted in the local pharmacies of the Veneto Region (2012) (0)
and Mark van Ommeren depression : systematic review and meta-analysis Efficacy of antidepressants and benzodiazepines in minor data (2010) (0)
Acknowledgement to assessors (2012) (0)
COMAD : COmprehensive Meta-Analysis for Depression [ PROTOCOL ] (2012) (0)
P.6.035 Diffusion-weighted MRI study of corpus callosum in patients with schizophrenia. Preliminary findings (2003) (0)
Chapter 36 Understanding and using systematic literature reviews (2011) (0)
Women In Surgery Italia: Perceived Gender Bias Among Italian Surgeons (2020) (0)
International dose differences in fluoxetine clinical trials conducted in patients with depression (2005) (0)
EPS volume 15 issue 4 Cover and Front matter (2006) (0)
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone (2008) (0)
S2045796019000027jra 376..388 (2019) (0)
JAMA Psychiatry Peer Reviewer List. (2017) (0)
Do selective serotonin reuptake inhibitors cause suicide? Author's reply (2005) (0)
Effectiveness of selective serotonin reuptake inhibitors - Response (2008) (0)
P.220 Early cardio-metabolic occurrences after atypical antipsychotic treatment initiation: Real world evidence from a large Italian claim database (2019) (0)
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries (2022) (0)
Fluoxetine top of the ranking for GAD: garbage in, garbage out? (2018) (0)
Efficacy of interventions to reduce coercive practices in mental health care: umbrella review of randomised trials (2020) (0)
Thanks to Reviewers2015 (2015) (0)
Efficacy of psychological interventions for PTSD in distinct populations - An evidence map of meta-analyses using the umbrella review methodology. (2022) (0)
P.3.12 Abnormalities of corpus callosum in schizophrenia: a diffusion-weighted MRI study (2004) (0)
The attitude of patients with mental disorders towards pharmacological and non-pharmacological treatments: emerging implications for clinical practice, service organization and research (2008) (0)
PP063—Changes in the utilisation of venlafaxine after the introduction of generics in Sweden: Implications for other countries (2013) (0)
Clotiapine for schizophrenia (2007) (0)
INTERVENTIONS INTERVENTIONS IN MILD TO MODERATE, OR SE- VERE DEPRESSION (2007) (0)
Effectiveness of selective serotonin reuptake inhibitors (2008) (0)
Resilience of people with chronic medical conditions during the COVID-19 pandemic: a 1-year longitudinal prospective survey (2022) (0)
Esketamine for treatment-resistant depression in adults (2022) (0)
Subject Index Vol. 40, 2007 (2007) (0)
Fluoxetine and amitriptyline: First-line treatments or reference compounds? (2004) (0)
Corrections. Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis. (2015) (0)
Acknowledgement to Referees (2014) (0)
Pharmacoeconomic evaluations on anti psychotics in schizophrenia: a review of the Italian studies (2006) (0)
Frequency and adequacy of depression treatment in Alberta, Canada (2007) (0)
When important steps for a reliable meta-analysis are missing: the bevacizumab versus ranibizumab case. (2015) (0)
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders (2012) (0)
[Second-generation antipsychotics and cardio-metabolic events: real-world analysis and healthcare costs]. (2021) (0)
Effectiveness of a stepped-care programme of WHO psychological interventions in migrant populations resettled in Italy: Study protocol for the RESPOND randomized controlled trial (2023) (0)
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions? (2022) (0)
Head-to-head economic comparisons between atypical antipsychotics: are there any relevant differences? A systematic review (2005) (0)
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study. (2023) (0)
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial (2014) (0)
Risk factors for mental disorder development in asylum seekers and refugees resettled in Western Europe and Turkey: Participant-level analysis of two large prevention studies (2022) (0)
A comparison of physical health in migrants and natives accessing Psychiatric Services: An explorative study on data from the Verona Psychiatric Case Register (2018) (0)
Generic olanzapine: health authority opportunity (2008) (0)
Role of Co-occurring Alcohol and Substances Abuse on QTc Interval Prolongation Among Psychiatric Patients: A Cross-sectional National Survey (2017) (0)
Review: limited evidence that adding a second antipsychotic improves clozapine treatment in schizophrenia (2009) (0)
Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review (2023) (0)
Subject Index Vol. 74, 2005 (2005) (0)
Efficacy and tolerability profile of escitalopram versus other antidepressants in the acute treatment of major depressive disorder: A systematic review and meta-analysis (2007) (0)
3D reconstruction technique of perfusion MRI in schizophrenia (2004) (0)
Contents Vol. 40, 2007 (2007) (0)
Reply (2005) (0)
Can systematic reviews contribute to regulatory decisions? (2017) (0)
Cognitive improvements with antipsychotics: real or practice effect? (2008) (0)
META-ANALYSIS OF ANTIPSYCHOTIC DRUGS IN SCHIZOPHRENIA (2011) (0)
Italy's mad law (2000) (0)
TRYPTOPHAN AND DEPRESSION. AUTHORS' REPLY (1997) (0)
Comparative ef ﬁ cacy and tolerability of pharmacological interventions for attention-de ﬁ cit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis (2017) (0)
Efficacy and acceptability of antidepressants for the treatment of depressive symptoms in adult patients with ischemic heart disease (2018) (0)
Research synthesis: Systematic reviews and meta-analyses (2020) (0)
Salute to Our Reviewers. (2019) (0)
Supplementary Data (2018) (0)
A Practical Framework for Academics to Implement Public Engagement Interventions and Measure Their Impact (2022) (0)
Coping strategies among second victims of adverse events: A systematic review and meta-analysis (2018) (0)
Safety of esketamine nasal spray: Analysis of post-marketing reports submitted to the FDA adverse event reporting system in the first year on the market (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Corrado Barbui?

Corrado Barbui is affiliated with the following schools:

University of Milan
University of Verona
University of Padua
University of Ferrara